Compare Medtronic PLC (MDT) vs Tesla, Inc. (TSLA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medtronic PLC vs Tesla, Inc. — how do they compare? Medtronic PLC trades at $82.56 (market cap $106.61B), while Tesla, Inc. trades at $381.13 (market cap $1.39T). The key difference: Tesla, Inc. is far larger — about 13× Medtronic PLC's market cap, and Medtronic PLC pays a 3.46% dividend while Tesla, Inc. pays none. Which is the better fit depends on your goals.
| MDT | TSLA | |
|---|---|---|
Market Cap | $106.61B | $1.39T |
Sector | Health | Consumer Cyclical |
52-Week High | $105.35 | $489.88 |
52-Week Low | $73.75 | $302.63 |
Enterprise Value | $125.36B | $1.36T |
Dividend Yield | 3.46% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $83.54, up 0.41% today, with a bullish technical signal from moving averages. The company reported strong revenue growth to $33.54B in 2025 and has beaten EPS estimates for three consecutive quarters. Recent acquisitions, including SPR and Scientia Vascular, expand its pain therapy and neurovascular portfolios. Valuation ratios show a P/E of 22.31 and P/S of 2.95, with a consensus price target of $97.50 implying significant upside.
The outlook is positive, supported by robust fundamentals, analyst optimism, and strategic expansions. Key risks include rising debt levels and competitive pressures in medical technology. With no sell ratings from analysts and a dividend yield near a decade high, MDT presents a compelling long-term opportunity for growth and income investors, though macroeconomic and execution risks warrant monitoring.
Tesla trades at $381.64, up 0.21% on the day, amid a bearish technical signal and mixed earnings history. The stock faces valuation concerns with a P/E of 339.06 and P/S of 13.34, while profitability metrics like net income margin have declined to 3.95% in 2025. Recent news highlights regulatory approval for self-driving software in Europe and a potential cheaper EV launch, but delivery misses and competitive pressures weigh on sentiment.
Tesla's outlook balances innovation in autonomy and energy against slowing auto growth and high valuations. Investment opportunities lie in AI and robotics expansion, but risks include execution challenges, intense EV competition, and reliance on future technology adoption. Analyst consensus is mixed with a $409.26 price target, suggesting cautious optimism amid near-term headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →About Tesla, Inc.
Tesla Inc. designs, manufactures, and sells high-performance electric vehicles and electric vehicle powertrain components. The Company owns its sales and service network and sells electric power train components to other automobile manufacturers. Tesla serves customers worldwide.
Read more on TSLA →
